LICN — Stock Film
STOCK FILMSCENE 1/11LICN · $1.04
Stock Expert AI presents
LICN
Lichen International Limited
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Lichen International Limited. What it actually does.

Provide comprehensive financial advisory services to businesses and individuals. Offer expert tax consultation, ensuring compliance and optimizing fiscal strategies. Now — the numbers.

on the stock market since 2023
410 employees
$792K market value
Revenue last year:
$24.5M
The loss that same year:
$22M
For every $1 it earns, the company spends $1.9.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales have been shrinking.

An average decline of 8% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$34.3M
2021
2022
2023
2024
$24.5M
2025
In the vault right now:
$26.9M
DEBT: $554K
At this pace, that money lasts about 1.2 years.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
8
very weak

Clearly below the class average.

FINANCIAL STRENGTH
86
very strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
52
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
38
weak

Clearly below the class average.

PRICE MOMENTUM
7
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
Little set aside for the future2/10
Sales are shrinking4/10
Costs eat into the margin4/10
WORTH WATCHING

R&D Investment: Spending on future research is low.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
The product is selling

Sales run at $24.5M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $22.0M against $24.5M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts about 1.2 years. After that, the company needs to find new money.

FINALE · THE GRADE
grade pending

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film